Boston Scientific Corporation (BSX) on Decifer

Decifer ranks BSX number 158 of 268 tracked names on durable business quality.

Why it ranks here

• Sales are growing about 20% a year, faster than 68 in 100 companies we measure.
• It keeps about 18 cents of every sales dollar as cash, safer than 80 in 100 companies we measure.
• It earns about 8% a year on the money put into the business, better than 47 in 100 companies we measure.
• It costs about 18 times its yearly profit; the middle of its industry is 31. Cheaper than 83 in 100 companies we measure, against their own industries.

The current read

The evidence on BSX lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Robotic & Minimally-Invasive Intervention: Clinical and economic evidence favoring minimally invasive robotic and thrombectomy procedures is shifting procedure volumes and capital equipment budgets toward advanced interventional platforms.

Read the full BSX research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.